A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Participants With Guillain-Barr é Syndrome (GBS)

Condition:   Guillain-Barré Syndrome Interventions:   Drug: Crovalimab;   Drug: Placebo;   Drug: Intravenous immunoglobulin therapy Sponsors:   Hoffmann-La Roche;   Chugai Pharmaceutical Co., Ltd. (Sponsor in Taiwan and Japan) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials